full-year earn $ 1.46 billion $ 4.39 share
1990 $ 1.14 billion $ 3.43 share earn
1990 includ nonrecur charg $ 125 million 38
cent share most due write restructur
unit argentina pay addit interest
compani debt countri impact monetari
restrict impos brazil without charg earn
1990 $ 1.27 billion $ 3.81 share
sale year rose 11 % $ 12.48 billion $ 11.23
billion strong dollar hurt sale less 1 %
$ 106 million
kenneth abramowitz analyst sanford c. bernstein
co. said compani earn slight better
expect
compani continu deliv 15 % earn growth
make wall street happi invest rest
research develop market mr. abramowitz said
ad essenti get earn growth
15 % larg compani grow 15 % year
compani underinvest jj said invest $ 1
billion research develop 1991 18 %
increas
pharmaceut sale rose 15 % worldwid u.s. volum
climb 16 % intern sale increas 14 % result
led sale gain prepulsid gastrointestin
drug sold outsid u.s. current await food
drug administr approv hisman antihistamin
profession segment sale rose 9.4 % world-wid
u.s. volum increas 12 % intern sale gain
6.9 % subsidiari includ ethicon sutur
less-invas surgeri instrument unit led sale growth
year
consum segment sale rose 8.8 % world-wid u.
sale increas 18 % intern volum remain flat
antacid mylanta product led sale gain
segment
johnson johnson stock rose $ 2.75 yesterday $ 106
late trade new york stock exchang
